- |||||||||| HSY244 / Novartis
Enrollment change, Trial completion date, Trial termination, Trial primary completion date: A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of HSY244 in Participants With Atrial Fibrillation (clinicaltrials.gov) - Apr 27, 2023 P2, N=13, Terminated, N=29 --> 13 | Trial completion date: Jul 2025 --> Jul 2022 | Recruiting --> Terminated | Trial primary completion date: Jul 2025 --> Jul 2022; Terminated due to business decision
|